|
| ID |
DDInter909 |
| Drug Type |
small molecule |
| Molecular Formula |
C29H31N7O |
| Molecular Weight |
493.615
|
| Description |
Imatinib is a tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors.
|
| ATC Classification |
L01XE01
|
| IUPAC Name |
N-(4-Methyl-3-{[4-(Pyridin-3-Yl)Pyrimidin-2-Yl]Amino}Phenyl)-4-[(4-Methylpiperazin-1-Yl)Methyl]Benzamide |
| InChI |
Inchi=1S/C29H31N7O/C1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/H3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34) |
| InChI Key |
KTUFNOKKBVMGRW-UHFFFAOYSA-N |
| Canonical SMILES |
CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|